Header Logo

Connection

Kate Lapane to Dementia

This is a "connection" page, showing publications Kate Lapane has written about Dementia.
Connection Strength

3.621
  1. Tjia J, Reidenberg MM, Hunnicutt JN, Paice K, Donovan JL, Kanaan A, Briesacher BA, Lapane KL. Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia. Consult Pharm. 2015 Oct; 30(10):599-611.
    View in: PubMed
    Score: 0.538
  2. Jalbert JJ, Daiello LA, Eaton CB, Miller SC, Lapane KL. Antipsychotic use and the risk of diabetes in nursing home residents with dementia. Am J Geriatr Pharmacother. 2011 Jun; 9(3):153-63.
    View in: PubMed
    Score: 0.397
  3. Parsons C, Hughes CM, Passmore AP, Lapane KL. Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? Drugs Aging. 2010 Jun 01; 27(6):435-49.
    View in: PubMed
    Score: 0.371
  4. Jalbert JJ, Eaton CB, Miller SC, Lapane KL. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc. 2010 Feb; 11(2):120-7.
    View in: PubMed
    Score: 0.362
  5. Gasper MC, Ott BR, Lapane KL. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia? Am J Geriatr Pharmacother. 2005 Mar; 3(1):1-7.
    View in: PubMed
    Score: 0.258
  6. Ott BR, Lapane KL. Tacrine therapy is associated with reduced mortality in nursing home residents with dementia. J Am Geriatr Soc. 2002 Jan; 50(1):35-40.
    View in: PubMed
    Score: 0.207
  7. Fernandez HH, Lapane KL. Estrogen use among nursing home residents with a diagnosis of Parkinson's disease. Mov Disord. 2000 Nov; 15(6):1119-24.
    View in: PubMed
    Score: 0.191
  8. Maclagan LC, Maxwell CJ, Harris DA, Campitelli MA, Diong C, Lapane KL, Hogan DB, Rochon P, Herrmann N, Bronskill SE. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada. Drugs Aging. 2020 11; 37(11):817-827.
    View in: PubMed
    Score: 0.190
  9. Maclagan LC, Bronskill SE, Guan J, Campitelli MA, Herrmann N, Lapane KL, Hogan DB, Amuah JE, Seitz DP, Gill SS, Maxwell CJ. Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission. J Am Med Dir Assoc. 2018 11; 19(11):959-966.e4.
    View in: PubMed
    Score: 0.165
  10. Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill SS, Gruneir A, Wodchis WP, Bronskill SE. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf. 2018 03; 27(3):289-298.
    View in: PubMed
    Score: 0.157
  11. Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, Mazor K, Hunnicutt JN, Lapane KL, Gurwitz J. Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes. J Am Geriatr Soc. 2017 01; 65(1):59-65.
    View in: PubMed
    Score: 0.143
  12. Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, Gambassi G. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009 Oct; 70(10):1340-7.
    View in: PubMed
    Score: 0.089
  13. Daiello LA, Ott BR, Lapane KL, Reinert SE, Machan JT, Dore DD. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Am J Geriatr Pharmacother. 2009 Apr; 7(2):74-83.
    View in: PubMed
    Score: 0.086
  14. Gruneir A, Lapane KL, Miller SC, Mor V. Does the presence of a dementia special care unit improve nursing home quality? J Aging Health. 2008 Oct; 20(7):837-54.
    View in: PubMed
    Score: 0.083
  15. Gruneir A, Lapane KL, Miller SC, Mor V. Is dementia special care really special? A new look at an old question. J Am Geriatr Soc. 2008 Feb; 56(2):199-205.
    View in: PubMed
    Score: 0.078
  16. Gruneir A, Lapane KL, Miller SC, Mor V. Long-term care market competition and nursing home dementia special care units. Med Care. 2007 Aug; 45(8):739-45.
    View in: PubMed
    Score: 0.076
  17. Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Bernabei R. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry. 2005 Sep; 66(9):1090-6.
    View in: PubMed
    Score: 0.067
  18. Fernandez HH, Lapane KL, Ott BR, Friedman JH. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov Disord. 2000 May; 15(3):490-6.
    View in: PubMed
    Score: 0.046
  19. Landi F, Gambassi G, Lapane KL, Sgadari A, Gifford D, Mor V, Bernabei R. Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord. 1998 Nov-Dec; 9(6):347-56.
    View in: PubMed
    Score: 0.042
  20. Tjia J, Hunnicutt JN, Herndon L, Blanks CR, Lapane KL, Wehry S. Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes. JAMA Intern Med. 2017 06 01; 177(6):846-853.
    View in: PubMed
    Score: 0.038
  21. Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada. Drugs Aging. 2017 01; 34(1):39-53.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.